Family · Pharmaceutical analytical standards
Atenolol
A beta-blocker selective for the heart's beta-1 receptors, patented in 1969 and approved in 1975: it is used for hypertension, angina and arrhythmias and is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It is among the least fat-soluble beta-blockers and barely enters the brain: there it reaches about one fifth of its blood concentration, whereas propranolol concentrates there 15 to 33 times more than in the blood.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
